ELLERY MURRAY: Open Payments
NPI 1669251971 · PROVIDENCE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,347 in 57 payments from 14 companies in 2025. Trend: 2023 $271 · 2024 $1,307 · 2025 $1,347
Food & beverage: $1,347
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $214 |
| Collegium Pharmaceutical, Inc. | 14 | $183 |
| Boston Scientific Corporation | 2 | $180 |
| Valinor Pharma, LLC | 11 | $180 |
| Lilly USA, LLC | 3 | $170 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $114 |
| PFIZER INC. | 3 | $71 |
| Novo Nordisk Inc | 3 | $62 |
| Averitas Pharma Inc. | 2 | $48 |
| Indivior Inc. | 1 | $39 |
Products named: XTAMPZA, Intracept, MOVANTIK, ZEPBOUND, JOURNAVX, QULIPTA, UBRELVY, NURTEC ODT.
Industry payments across RI — which companies pay providers there.
